<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365098">
  <stage>Registered</stage>
  <submitdate>4/10/2013</submitdate>
  <approvaldate>11/10/2013</approvaldate>
  <actrnumber>ACTRN12613001132730</actrnumber>
  <trial_identification>
    <studytitle> Interactions of osteocalcin, adiponectin, tumor necrosis factor alpha and insulin resistance in polycystic ovary syndrome </studytitle>
    <scientifictitle> Interactions of osteocalcin, adiponectin, tumor necrosis factor alpha and insulin resistance in polycystic ovary syndrome </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition> polycystic ovary syndrome </healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Other reproductive health and childbirth disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Blood levels of hormones  is assesed during administration to our clinic.  These are thyroid stimulating hormone, cortisol, dehydroepiandrosterone sulfate, prolactin, luteinizing hormone, follicle-stimulating hormone, estradiol, 17-hydroxyprogesterone, Androstenedione, Adiponectin, TNF alpha, osteocalcine, free testosterone, total testosterone, insulin and sex hormone binding globulin levels. We assessed at baseline and then again 6 months later.</interventions>
    <comparator>Participants are healthy controls. Blood levels of hormones  is assesed during administration to our clinic. These are thyroid stimulating hormone, cortisol, dehydroepiandrosterone sulfate, prolactin, luteinizing hormone, follicle-stimulating hormone, estradiol, 17-hydroxyprogesterone, Androstenedione, Adiponectin, TNF alpha, osteocalcine, free testosterone, total testosterone, insulin and sex hormone binding globulin levels. We assessed at baseline and then again 6 months later.</comparator>
    <control>Active</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>to evaluate the correlations of blood osteocalcin with IR, adiponectin, and TNF-a in PCOS and we matched these parameters with healthy controls</outcome>
      <timepoint>6 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Hormonal analyses included; thyroid stimulating hormone (TSH), cortisol, dehydroepiandrosterone sulfate (DHEAS), prolactin (PRL), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), 17-hydroxyprogesterone (17-OH-P), Androstenedione (A), free testosterone (fT), total testosterone (tT), insulin and sex hormone binding globulin (SHBG) levels. tT and fT (Biosource-Nivelles-Belgium), 17 OHP (DSL-3500, Texas USA), DHEAS (Immunotech, Marseille, France), A (DSL- 3800, Texas, USA) were measured by using an immunoradiometric assay method and its commercial kit, serum SHBG (Zentech, Angleur, Belgium), insulin (Biosource, Nivelles, Belgium), LH, FSH, P, PRL (ACS:180, Bayer, Germany) were measured by using a chemiluminescence method and its commercial kit.</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>A total of 74 women including 55 PCOS patients (group-1) and 19 healthy women (group-2) were studied.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Previous medication with hormone ( 6 months prior to study), liver disease, kidney disease, cardiac and vascular disorders   </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup>6</followup>
    <followuptype>Months</followuptype>
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Case control</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/11/2010</anticipatedstartdate>
    <actualstartdate>1/11/2010</actualstartdate>
    <anticipatedenddate>1/11/2012</anticipatedenddate>
    <actualenddate>1/11/2012</actualenddate>
    <samplesize>74</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Kayseri</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Erciyes University</primarysponsorname>
    <primarysponsoraddress>Erciyes University Talas Street Kayseri/Turkey 38010</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Erciyes University </fundingname>
      <fundingaddress>Erciyes University Talas Street  Kayseri/Turkey 38010</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress>None</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Objective: Insulin resistance (IR) seems to be main pathogenic factor in polycystic ovary syndrome (PCOS). Osteocalcin, adiponectin and tumor necrosis factor alpha (TNF-a) are also implicated from IR. The aim of this study was to evaluate the correlations of osteocalcin with IR, adiponectin, and TNF-a in PCOS. 
Study Design: A total of 74 women were divided into two groups. Group 1 was constituted from 55 PCOS patients and group 2 was constituted from 19 healthy women. Adiponectin, TNF-a, osteocalcine, hormonal levels, body mass index, IR in the fasting state were assessed and correlations of these parameters with each other were evaluated in 74 women.  
</summary>
    <trialwebsite />
    <publication>No we did not publish our data.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Erciyes University Ethics Committe</ethicname>
      <ethicaddress>Erciyes University Talas Street Kayseri/Turkey 38010</ethicaddress>
      <ethicapprovaldate>16/09/2011</ethicapprovaldate>
      <hrec>2011/369</hrec>
      <ethicsubmitdate>3/08/2011</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Gokhan Acmaz</name>
      <address>Kayseri Education and Research Hospital of Medicine Hastane Street Kocasinan/Kayseri 38210</address>
      <phone>90 352 338 21 49</phone>
      <fax />
      <email>gokhanacmaz@gmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Gokhan Acmaz</name>
      <address>Kayseri Education and Research Hospital of Medicine Hastane Street Kocasinan/Kayseri 38210</address>
      <phone>90 352 338 21 49</phone>
      <fax />
      <email>gokhanacmaz@gmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Gokhan Acmaz</name>
      <address>Kayseri Education and Research Hospital of Medicine Hastane Street Kocasinan/Kayseri 38210</address>
      <phone>90 352 338 21 49</phone>
      <fax />
      <email>gokhanacmaz@gmail.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>